1
|
Liu LS; Writing Group of 2010 Chinese
Guidelines for the Management of Hypertension: 2010 Chinese
guidelines for the management of hypertension. Zhonghua Xin Xue
Guan Bing Za Zhi. 39:579–615. 2011.In Chinese. PubMed/NCBI
|
2
|
Lee RC, Feinbaum RL and Ambros V: The C.
elegans heterochronic gene lin-4 encodes small RNAs with antisense
complementarity to lin-14. Cell. 75:843–854. 1993. View Article : Google Scholar : PubMed/NCBI
|
3
|
Zhao Y, Samal E and Srivastava D: Serum
response factor regulates a muscle-specific microRNA that targets
Hand2 during cardiogenesis. Nature. 436:214–220. 2005. View Article : Google Scholar : PubMed/NCBI
|
4
|
Alvarez-Garcia I and Miska EA: MicroRNA
functions in animal development and human disease. Development.
132:4653–4662. 2005. View Article : Google Scholar : PubMed/NCBI
|
5
|
Denli AM, Tops BB, Plasterk RH, Ketting RF
and Hannon GJ: Processing of primary microRNAs by the
Microprocessor complex. Nature. 432:231–235. 2004. View Article : Google Scholar : PubMed/NCBI
|
6
|
Gregory RI, Yan KP, Amuthan G, Chendrimada
T, Doratotaj B, Cooch N and Shiekhattar R: The microprocessor
complex mediates the genesis of microRNAs. Nature. 432:235–240.
2004. View Article : Google Scholar : PubMed/NCBI
|
7
|
Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J,
Lee J, Provost P, Rådmark O, Kim S and Kim VN: The nuclear RNase
III Drosha initiates microRNA processing. Nature. 425:415–419.
2003. View Article : Google Scholar : PubMed/NCBI
|
8
|
Pillai RS, Bhattacharyya SN and Filipowicz
W: Repression of protein synthesis by miRNAs: How many mechanisms.
Trends Cell Biol. 17:118–126. 2007. View Article : Google Scholar : PubMed/NCBI
|
9
|
Valencia-Sanchez MA, Liu J, Hannon GJ and
Parker R: Control of translation and mRNA degradation by miRNAs and
siRNAs. Genes Dev. 20:515–524. 2006. View Article : Google Scholar : PubMed/NCBI
|
10
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Lagos-Quintana M, Rauhut R, Yalcin A,
Meyer J, Lendeckel W and Tuschl T: Identification of
tissue-specific microRNAs from mouse. Curr Biol. 12:735–739. 2002.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Wang S, Aurora AB, Johnson BA, Qi X,
McAnally J, Hill JA, Richardson JA, Bassel-Duby R and Olson EN: The
endothelial-specific microRNA miR-126 governs vascular integrity
and angiogenesis. Dev Cell. 15:261–271. 2008. View Article : Google Scholar : PubMed/NCBI
|
13
|
Fish JE, Santoro MM, Morton SU, Yu S, Yeh
RF, Wythe JD, Ivey KN, Bruneau BG, Stainier DY and Srivastava D:
miR-126 regulates angiogenic signaling and vascular integrity. Dev
Cell. 15:272–284. 2008. View Article : Google Scholar : PubMed/NCBI
|
14
|
Zernecke A, Bidzhekov K, Noels H,
Shagdarsuren E, Gan L, Denecke B, Hristov M, Köppel T, Jahantigh
MN, Lutgens E, et al: Delivery of microRNA-126 by apoptotic bodies
induces CXCL12-dependent vascular protection. Sci Signal.
2:ra812009. View Article : Google Scholar : PubMed/NCBI
|
15
|
Harris TA, Yamakuchi M, Ferlito M, Mendell
JT and Lowenstein CJ: MicroRNA-126 regulates endothelial expression
of vascular cell adhesion molecule 1. Proc Natl Acad Sci USA.
105:1516–1521. 2008. View Article : Google Scholar : PubMed/NCBI
|
16
|
Stumpf C, John S, Jukic J, Yilmaz A, Raaz
D, Schmieder RE, Daniel WG and Garlichs CD: Enhanced levels of
platelet P-selectin and circulating cytokines in young patients
with mild arterial hypertension. J Hypertens. 23:995–1000. 2005.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Cai J, Yi FF, Yang L, Shen DF, Yang Q, Li
A, Ghosh AK, Bian ZY, Yan L, Tang QZ, et al: Targeted expression of
receptor-associated late transducer inhibits maladaptive
hypertrophy via blocking epidermal growth factor receptor
signaling. Hypertension. 53:539–548. 2009. View Article : Google Scholar : PubMed/NCBI
|
18
|
Cai J, Yi FF, Bian ZY, Shen DF, Yang L,
Yan L, Tang QZ, Yang XC and Li H: Crocetin protects against cardiac
hypertrophy by blocking MEK-ERK1/2 signalling pathway. J Cell Mol
Med. 13:909–925. 2009. View Article : Google Scholar : PubMed/NCBI
|
19
|
Chen CZ, Li L, Lodish HF and Bartel DP:
MicroRNAs modulate hematopoietic lineage differentiation. Science.
303:83–86. 2004. View Article : Google Scholar
|
20
|
Fire A, Xu S, Montgomery MK, Kostas SA,
Driver SE and Mello CC: Potent and specific genetic interference by
double-stranded RNA in Caenorhabditis elegans. Nature. 391:806–811.
1998. View Article : Google Scholar : PubMed/NCBI
|
21
|
Caplen NJ: Gene therapy progress and
prospects. Downregulating gene expression: The impact of RNA
interference. Gene Ther. 11:1241–1248. 2004. View Article : Google Scholar : PubMed/NCBI
|
22
|
Wall NR and Shi Y: Small RNA: Can RNA
interference be exploited for therapy. Lancet. 362:1401–1403. 2003.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Uchida H, Tanaka T, Sasaki K, Kato K,
Dehari H, Ito Y, Kobune M, Miyagishi M, Taira K, Tahara H and
Hamada H: Adenovirus-mediated transfer of siRNA against survivin
induced apoptosis and attenuated tumor cell growth in vitro and in
vivo. Mol Ther. 10:162–171. 2004. View Article : Google Scholar : PubMed/NCBI
|
24
|
McCaffrey AP, Nakai H, Pandey K, Huang Z,
Salazar FH, Xu H, Wieland SF, Marion PL and Kay MA: Inhibition of
hepatitis B virus in mice by RNA interference. Nat Biotechnol.
21:639–644. 2003. View
Article : Google Scholar : PubMed/NCBI
|
25
|
Randall G, Grakoui A and Rice CM:
Clearance of replicating hepatitis C virus replicon RNAs in cell
culture by small interfering RNAs. Proc Natl Acad Sci USA.
100:235–240. 2003. View Article : Google Scholar : PubMed/NCBI
|
26
|
Ding H, Schwarz DS, Keene A, Affar B,
Fenton L, Xia X, Shi Y, Zamore PD and Xu Z: Selective silencing by
RNAi of a dominant allele that causes amyotrophic lateral
sclerosis. Aging Cell. 2:209–217. 2003. View Article : Google Scholar : PubMed/NCBI
|
27
|
Rubinson DA, Dillon CP, Kwiatkowski AV,
Sievers C, Yang L, Kopinja J, Rooney DL, Zhang M, Ihrig MM, McManus
MT, et al: A lentivirus-based system to functionally silence genes
in primary mammalian cells, stem cells and transgenic mice by RNA
interference. Nat Genet. 33:401–406. 2003. View Article : Google Scholar : PubMed/NCBI
|
28
|
Vázquez J, Correa de Adjounian MF, Sumners
C, González A, Diez-Freire C and Raizada MK: Selective silencing of
angiotensin receptor subtype 1a (AT1aR) by RNA interference.
Hypertension. 45:115–119. 2005. View Article : Google Scholar
|
29
|
Schober A, Nazari-Jahantigh M, Wei Y,
Bidzhekov K, Gremse F, Grommes J, Megens RT, Heyll K, Noels H,
Hristov M, et al: MicroRNA-126-5p promotes endothelial
proliferation and limits atherosclerosis by suppressing Dlk1. Nat
Med. 20:368–376. 2014. View Article : Google Scholar : PubMed/NCBI
|
30
|
Zhang J, Zhang Z, Zhang DY, Zhu J, Zhang T
and Wang C: MicroRNA 126 inhibits the transition of endothelial
progenitor cells to mesenchymal cells via the PIK3R2-PI3K/Akt
signalling pathway. PLoS One. 8:e832942013. View Article : Google Scholar : PubMed/NCBI
|
31
|
Goerke SM, Kiefer LS, Stark GB, Simunovic
F and Finkenzeller G: miR-126 modulates angiogenic growth
parameters of peripheral blood endothelial progenitor cells. Biol
Chem. 396:245–252. 2015. View Article : Google Scholar
|
32
|
Chen Y, Chen H, Hoffmann A, Cool DR, Diz
DI, Chappell MC, Chen AF and Morris M: Adenovirus-mediated
small-interference RNA for in vivo silencing of angiotensin AT1a
receptors in mouse brain. Hypertension. 47:230–237. 2006.
View Article : Google Scholar
|
33
|
Fridman E, Dotan Z, Barshack I, David MB,
Dov A, Tabak S, Zion O, Benjamin S, Benjamin H, Kuker H, et al:
Accurate molecular classification of renal tumors using microRNA
expression. J Mol Diagn. 12:687–696. 2010. View Article : Google Scholar : PubMed/NCBI
|
34
|
Zhang J, Du YY, Lin YF, Chen YT, Yang L,
Wang HJ and Ma D: The cell growth suppressor, mir-126, targets
IRS-1. Biochem Biophys Res Commun. 377:136–140. 2008. View Article : Google Scholar : PubMed/NCBI
|
35
|
Wang F, Zheng Z, Guo J and Ding X:
Correlation and quantitation of microRNA aberrant expression in
tissues and sera from patients with breast tumor. Gynecol Oncol.
119:586–593. 2010. View Article : Google Scholar : PubMed/NCBI
|
36
|
Miko E, Czimmerer Z, Csánky E, Boros G,
Buslig J, Dezso B and Scholtz B: Differentially expressed microRNAs
in small cell lung cancer. Exp Lung Res. 35:646–664. 2009.
View Article : Google Scholar : PubMed/NCBI
|
37
|
Li XM, Wang AM, Zhang J and Yi H:
Downregulation of miR-126 expression in colorectal cancer and its
clinical significance. Med Oncol. 28:1054–1057. 2011. View Article : Google Scholar
|
38
|
Tavazoie SF, Alarcón C, Oskarsson T, Padua
D, Wang Q, Bos PD, Gerald WL and Massagué J: Endogenous human
microRNAs that suppress breast cancer metastasis. Nature.
451:147–152. 2008. View Article : Google Scholar : PubMed/NCBI
|
39
|
Fulci V, Colombo T, Chiaretti S, Messina
M, Citarella F, Tavolaro S, Guarini A, Foà R and Macino G:
Characterization of B- and T-lineage acute lymphoblastic leukemia
by integrated analysis of MicroRNA and mRNA expression profiles.
Genes Chromosomes Cancer. 48:1069–1082. 2009. View Article : Google Scholar : PubMed/NCBI
|
40
|
Cammarata G, Augugliaro L, Salemi D,
Agueli C, La Rosa M, Dagnino L, Civiletto G, Messana F, Marfia A,
Bica MG, et al: Differential expression of specific microRNA and
their targets in acute myeloid leukemia. Am J Hematol. 85:331–339.
2010.PubMed/NCBI
|
41
|
Lever AM, Strappe PM and Zhao J:
Lentiviral vectors. J Biomed Sci. 11:439–449. 2004. View Article : Google Scholar : PubMed/NCBI
|
42
|
Lois C, Hong EJ, Pease S, Brown EJ and
Baltimore D: Germline transmission and tissue-specific expression
of transgenes delivered by lentiviral vectors. Science.
295:868–872. 2002. View Article : Google Scholar : PubMed/NCBI
|
43
|
Pfeifer A, Ikawa M, Dayn Y and Verma IM:
Transgenesis by lentiviral vectors: Lack of gene silencing in
mammalian embryonic stem cells and preimplantation embryos. Proc
Natl Acad Sci USA. 99:2140–2145. 2002. View Article : Google Scholar : PubMed/NCBI
|
44
|
Lai Z and Brady RO: Gene transfer into the
central nervous system in vivo using a recombinanat lentivirus
vector. J Neurosci Res. 67:363–371. 2002. View Article : Google Scholar : PubMed/NCBI
|
45
|
Zufferey R, Dull T, Mandel RJ, Bukovsky A,
Quiroz D, Naldini L and Trono D: Self-inactivating lentivirus
vector for safe and efficient in vivo gene delivery. J Virol.
72:9873–9880. 1998.PubMed/NCBI
|
46
|
Yu X, Zhan X, D'Costa J, Tanavde VM, Ye Z,
Peng T, Malehorn MT, Yang X, Civin CI and Cheng L: Lentiviral
vectors with two independent internal promoters transfer high-level
expression of multiple transgenes to human hematopoietic
stem-progenitor cells. Mol Ther. 7:827–838. 2003. View Article : Google Scholar : PubMed/NCBI
|
47
|
Lifton RP, Gharavi AG and Geller DS:
Molecular mechanisms of human hypertension. Cell. 104:545–556.
2001. View Article : Google Scholar : PubMed/NCBI
|
48
|
Wilson EM, Diwan A, Spinale FG and Mann
DL: Duality of innate stress responses in cardiac injury, repair,
and remodeling. J Mol Cell Cardiol. 37:801–811. 2004. View Article : Google Scholar : PubMed/NCBI
|
49
|
Fernandez-Real JM, Vayreda M, Richart C,
Gutierrez C, Broch M, Vendrell J and Ricart W: Circulating
interleukin 6 levels, blood pressure, and insulin sensitivity in
apparently healthy men and women. J Clin Endocrinol Metab.
86:1154–1159. 2001. View Article : Google Scholar : PubMed/NCBI
|
50
|
Moon SK, Cha BY and Kim CH: ERK1/2
mediates TNF-alpha-induced matrix metalloproteinase-9 expression in
human vascular smooth muscle cells via the regulation of NF-kappaB
and AP-1: Involvement of the ras dependent pathway. J Cell Physiol.
198:417–427. 2004. View Article : Google Scholar : PubMed/NCBI
|
51
|
Coles B, Fielding CA, Rose-John S,
Scheller J, Jones SA and O'Donnell VB: Classic interleukin-6
receptor signaling and interleukin-6 trans-signaling differentially
control angiotensin II-dependent hypertension, cardiac signal
transducer and activator of transcription-3 activation, and
vascular hypertrophy in vivo. Am J Pathol. 171:315–325. 2007.
View Article : Google Scholar : PubMed/NCBI
|
52
|
Davis JR, Giardina JB, Green GM, Alexander
BT, Granger JP and Khalil RA: Reduced endothelial NO-cGMP vascular
relaxation pathway during TNF-alpha-induced hypertension in
pregnant rats. Am J Physiol Regul Integr Comp Physiol.
282:R390–R399. 2002. View Article : Google Scholar : PubMed/NCBI
|
53
|
Shesely EG, Maeda N, Kim HS, Desai KM,
Krege JH, Laubach VE, Sherman PA, Sessa WC and Smithies O: Elevated
blood pressures in mice lacking endothelial nitric oxide synthase.
Proc Natl Acad Sci USA. 93:13176–13181. 1996. View Article : Google Scholar : PubMed/NCBI
|
54
|
Chin K, Kurashima Y, Ogura T, Tajiri H,
Yoshida S and Esumi H: Induction of vascular endothelial growth
factor by nitric oxide in human glioblastoma and hepatocellular
carcinoma cells. Oncogene. 15:437–442. 1997. View Article : Google Scholar : PubMed/NCBI
|
55
|
Gélinas DS, Bernatchez PN, Rollin S, Bazan
NG and Sirois MG: Immediate and delayed VEGF-mediated NO synthesis
in endothelial cells: Role of PI3K, PKC and PLC pathways. Br J
Pharmacol. 137:1021–1030. 2002. View Article : Google Scholar : PubMed/NCBI
|
56
|
Miska EA, Alvarez-Saavedra E, Townsend M,
Yoshii A, Sestan N, Rakic P, Constantine-Paton M and Horvitz HR:
Microarray analysis of microRNA expression in the developing
mammalian brain. Genome Biol. 5:R682004. View Article : Google Scholar : PubMed/NCBI
|
57
|
Chivukula RR and Mendell JT: Circular
reasoning: microRNAs and cell-cycle control. Trends Biochem Sci.
33:474–481. 2008. View Article : Google Scholar : PubMed/NCBI
|
58
|
Pan Q and Chegini N: MicroRNA signature
and regulatory functions in the endometrium during normal and
disease states. Semin Reprod Med. 26:479–493. 2008. View Article : Google Scholar : PubMed/NCBI
|
59
|
Fontana L, Sorrentino A, Condorelli G and
Peschle C: Role of microRNAs in haemopoiesis, heart hypertrophy and
cancer. Biochem Soc Trans. 36:1206–1210. 2008. View Article : Google Scholar : PubMed/NCBI
|
60
|
Finnegan EJ and Matzke MA: The small RNA
world. J Cell Sci. 116:4689–4693. 2003. View Article : Google Scholar : PubMed/NCBI
|
61
|
Liu B, Peng XC, Zheng XL, Wang J and Qin
YW: MiR-126 restoration down-regulate VEGF and inhibit the growth
of lung cancer cell lines in vitro and in vivo. Lung Cancer.
66:169–175. 2009. View Article : Google Scholar : PubMed/NCBI
|